Last reviewed · How we verify

NCT07520513: CGF

Socket Shield Technique With CGF and Xenograft for Immediate Implants

Not yet recruiting NA Last updated 13 April 2026
What this trial tests

NA trial testing Socket Shield Technique with Immediate Implant Placement and CGF + Xenograft in Alveolar Bone Loss in 7 participants. Not yet recruiting.

Timeline
5 April 2026
Primary endpoint
1 September 2026
30 December 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment7
Start date5 April 2026
Primary completion1 September 2026
Estimated completion30 December 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

18 and older, any sex, with Alveolar Bone Loss or Socket Shield Technique. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective case series aims to evaluate the clinical and radiographic outcomes of immediate implant placement using the socket shield technique combined with concentrated growth factors (CGF) and xenograft in the esthetic zone. The study will assess crestal bone level changes and implant stability over a 6-month follow-up period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07520513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing